The Cooperative Republic of Guyana will benefit from US$6 million in vaccine financing from the World Bank.
In a release the bank announced that it has approved the disbursement to support the Guyana COVID-19 Emergency Response Project, which facilitates affordable and equitable access to COVID-19 vaccines and ensure effective vaccine deployment in the South American country.
“The World Bank is closely coordinating with development partners and Government of Guyana counterparts to support the vaccination campaign, and long-term improvements to the country’s health care system”
In addition, the project promotes general preparedness, resilience, and the overall strengthening of the health system.
“An efficient and equitable roll-out of COVID-19 vaccines will be critical to save lives and restore economic activities in Guyana,” Ozan Sevimli, World Bank Resident Representative for Jamaica and Guyana, stated.
“The World Bank is closely coordinating with development partners and Government of Guyana counterparts to support the vaccination campaign, and long-term improvements to the country’s health care system,” he continued.
In additional to the Guyana COVID-19 Emergency Response Project helping to fund the acquisition of COVID-19 vaccines, it will also aid the Government of Guyana strengthen health system functions that are necessary for immunization, such as vaccine awareness communication, human resources, information systems, and waste management.
“The additional financing to this project also aims to increase overall health system preparedness to tackle future emergencies,” the World Bank said.
In its original form, the Guyana COVID-19 Emergency Response Project, aimed to support the country’s pandemic response and strengthen the country’s health system. Last November, the World Bank approved an interest-free, US$5 million loan through the International Development Association for a period of 40 years.
The additional US$1 million is a grant from the Health Emergency Preparedness and Response Multi-Donor Trust Fund, through which the bank is providing US$12 billion to help low- and middle-income countries purchase and distribute COVID-19 vaccines, tests, and treatments.